|
C14ORF129 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.135500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.537800E-02 |
| Normal-vs-Stage2 |
1.787180E-01 |
| Normal-vs-Stage3 |
1.638400E-02 |
| Normal-vs-Stage4 |
1.869020E-01 |
| Stage1-vs-Stage2 |
6.921000E-01 |
| Stage1-vs-Stage3 |
8.722400E-02 |
| Stage1-vs-Stage4 |
4.818600E-01 |
| Stage2-vs-Stage3 |
2.652400E-01 |
| Stage2-vs-Stage4 |
7.396400E-01 |
| Stage3-vs-Stage4 |
5.465000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.019900E-02 |
| Normal-vs-AfricanAmerican |
6.941200E-03 |
| Normal-vs-Asian |
2.980800E-01 |
| Caucasian-vs-AfricanAmerican |
1.140770E-01 |
| Caucasian-vs-Asian |
4.769000E-01 |
| AfricanAmerican-vs-Asian |
5.984200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.100200E-02 |
| Normal-vs-Female |
7.350000E-04 |
| Male-vs-Female |
2.221500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.348400E-01 |
| Normal-vs-Extreme_Weight |
2.110400E-01 |
| Normal-vs-Obese |
5.276500E-03 |
| Normal-vs-Extreme_Obese |
4.575200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.618800E-01 |
| Normal_Weight-vs-Obese |
1.785600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.694600E-01 |
| Extreme_Weight-vs-Obese |
6.916100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.802800E-01 |
| Obese-vs-Extreme_Obese |
5.435200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.481000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.821200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.686600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.260400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.673700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.779500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.403500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.154600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.472100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.012000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.776700E-03 |
| Normal-VS-Type2 PRCC |
4.137800E-01 |
| Normal-VS-KIRP CIMP |
1.416150E-02 |
| Normal-VS-Unclassified PRCC |
8.410000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.248800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.040310E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.596000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.676700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.991800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.702200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.271600E-01 |
| Normal-vs-N1 |
3.383400E-03 |
| Normal-vs-N2 |
6.339000E-01 |
| N0-vs-N1 |
1.065780E-02 |
| N0-vs-N2 |
6.133400E-01 |
| N1-vs-N2 |
1.348580E-01 |
|
|
